Reich K, Cullen E, Weinberg M. Maintenance of response in moderate-to-severe psoriasis after withdrawal of the IL-17A and IL-17F nanobody sonelokimab - Is there a role for IL-17F in disease reoccurrence? Br J Dermatol 2022 Apr 20. doi: 10.1111/bjd.21617.
PMID: 35442535